B-type natriuretic Peptide: application in the community

Congest Heart Fail. 2008 Jul-Aug;14(4 Suppl 1):12-6. doi: 10.1111/j.1751-7133.2008.tb00004.x.


Natriuretic peptide assessment has represented a significant advance in the management of heart failure. In a syndrome in which clinical symptoms and signs can be either nonspecific or absent, the presence of a reliable biomarker to aid diagnosis, assess prognosis, and potentially guide treatment and aid in prevention of this syndrome has represented a significant advance. The following review will outline established and potential new roles for natriuretic peptide assessment in the community.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Heart Failure / diagnosis*
  • Heart Failure / physiopathology
  • Humans
  • Mass Screening
  • Natriuretic Peptide, Brain*
  • Prognosis
  • Risk Assessment
  • Risk Factors


  • Natriuretic Peptide, Brain